Vasoprotective effect of effective lipid-lowering therapy in patients with <i>ST</i>-segment elevation myocardial infarction

Vasoprotective effect of effective lipid-lowering therapy in patients with <i>ST</i>-segment elevation myocardial infarction

Aim. To study the vasoprotective effects of atorvastatin depending on the achievement of the target level of low-density lipoprotein cholesterol (LDL-C) in patients with ST-segment elevation myocardial infarction (STEMI) within 48 weeks of follow-up. Materials and methods. Included were 112 STEMI...

Full description

Bibliographic Details
Main Authors:	Ludmila I. Salyamova, Angelina A. Khromova, Olga G. Kvasova, Irina V. Avdeeva, Natalia A. Borisova, Karina N. Korenkova, Kristina N. Polezhaeva, Valentin E. Oleynikov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2023-01-01
Series:	Терапевтический архив
Subjects:	st-segment elevation myocardial infarction atorvastatin arterial stiffness
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/77531/pdf

Similar Items

Pleiotropic vasoprotective effects of high-dose atorvastatin therapy in the context of achieving the target low-density lipoprotein cholesterol in patients after myocardial infarction
by: L. I. Salyamova, et al.
Published: (2022-08-01)

Vasoprotective statin effectiveness in patients with carotid atherosclerosis
by: Yu. B. Belousov, et al.
Published: (2007-10-01)

Cardiac Magnetic Resonance Imaging Based Ischemic Injury Pattern in Patients with Acute Myocardial Infarction Sensu Left Ventricular Global Systolic Function
by: Lyudmila Salyamova, et al.
Published: (2024-03-01)

Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-05-01)

EFFECTS OF ATORVASTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND DYSLIPIDEMIA
by: N. M. Nikitina, et al.
Published: (2014-07-01)

EFFECTS OF ATORVASTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND DYSLIPIDEMIA
by: N. M. Nikitina, et al.
Published: (2014-07-01)

Possibilities of noninvasive diagnostics of cardiovascular diseases associated with atherosclerosis
by: Lyudmila I. Salyamova, et al.
Published: (2024-05-01)

The effect of SARS-CoV-2 infection on structural and functioal properties of arteries
by: I.V. Avdeeva, et al.
Published: (2022-06-01)

Complete interventional revascularization versus infarct-related artery revascularization only in SТЕМI patients – part I
by: Iskra Bayraktarova, et al.
Published: (2020-10-01)

ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
by: V. E. Oleynikov, et al.
Published: (2015-11-01)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
by: Elin Chorell, et al.
Published: (2020-12-01)

MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: L. I. Salyamova, et al.
Published: (2018-05-01)

The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction
by: Lotta Ulander, et al.
Published: (2023-09-01)

Significance of C-Reactive Protein in Patients with ST-Elevation Myocardial Infarction Over Non-ST-Elevation Myocardial Infarction
by: Shahzadi Anum, et al.
Published: (2023-01-01)

Long-term outcomes and predictors of patients with ST elevated versus non-ST elevated myocardial infarctions in non-obstructive coronary arteries: a retrospective study in Northern China
by: Lin Chen, et al.
Published: (2023-03-01)

Aortic Stiffness and Infarct Healing in Survivors of Acute ST‐Segment–Elevation Myocardial Infarction
by: Martin Reindl, et al.
Published: (2020-02-01)

Conventional risk factors and arterial bed parameters in patients with coronary artery disease younger and older than 50 years
by: A. A. Khromova, et al.
Published: (2020-09-01)

LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION
by: N. E. Zakirova, et al.
Published: (2016-05-01)

The role of <i>SELE</i> gene polymorphism in ST-elevation myocardial infarction
by: N. P. Babushkina, et al.
Published: (2025-03-01)

Prediction of Adverse Post-Infarction Left Ventricular Remodeling Using a Multivariate Regression Model
by: Valentin Oleynikov, et al.
Published: (2022-03-01)

IMPROVEMENT OF RETHROMBOSIS DIAGNOSTICS IN STEACS PATIENTS WITH USE OF TELEMONITORING OF ECG
by: V. E. Oleynikov, et al.
Published: (2014-09-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Prediction of coronary atherosclerosis in young patients with coronary artery disease using a non-invasive biomarker
by: V. E. Oleinikov, et al.
Published: (2020-12-01)

A One-Step Sample Processing Method in Combination with HPLC-MS/MS for the Simultaneous Quantification of Atorvastatin, Ezetimibe and Three Metabolites including <i>o</i>-Hydroxyl Atorvastatin, <i>p</i>-Hydroxyl Atorvastatin, and Ezetimibe-Glucuronide in Human Plasma
by: T. Nguyen Nguyen Le, et al.
Published: (2023-07-01)

EFFECTS OF COMBINATION THERAPY ON PLATELET COUNT IN PATIENTS OF MYOCARDIAL INFARCTION
by: Sadaf Ahmed, et al.
Published: (2014-12-01)

What Do Guidelines Say We Should Do in Patients with ST Elevation Myocardial Infarction?
by: Onur Akpınar, et al.
Published: (2014-12-01)

Comparison of Short Term In-Hospital Outcomes in patients presenting with ST-Elevation Myocardial Infarction Versus Non-ST-Elevation Myocardial Infarction
by: Masood Khan, et al.
Published: (2023-12-01)

The Pattern of reciprocal electrocardiography changes in St-segment elevation myocardial infarction patients presenting with single-vessel disease versus multi-vessel disease
by: Mohamed Elsayed Zahran
Published: (2019-01-01)

Hyperkalemia Mimicking Anteroseptal Myocardial Infarction
by: Raka Aldy Nugraha, et al.
Published: (2023-10-01)

Persistent electrocardiographic ST segment elevation from previous myocarditis
by: Efrén Martinez-Quintana, et al.
Published: (2013-01-01)

ECG patterns suggestive of high-risk coronary anatomy in non-ST-segment elevation acute coronary syndrome – an analysis of real-world patients
by: Natalia Gołąbek, et al.
Published: (2023-10-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

Pleiotropic Long-Term Effects of Atorvastatin on Posttraumatic Joint Contracture in a Rat Model
by: Erik Wegner, et al.
Published: (2022-02-01)

EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK
by: V. E. Oleynikov, et al.
Published: (2016-06-01)

Structural and functional properties of arteries in COVID-19 survivors
by: V. E. Oleinikov, et al.
Published: (2023-06-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

Effect of atorvastatin nanoparticles compared to free atrovastatin on plaque properties in rabbit model of atherosclerosis
by: Anjuman Arora, et al.
Published: (2019-01-01)

Smoker pseudo-paradox in ST-segment elevation myocardial infarction patients
by: Parisa Janjani, et al.
Published: (2023-04-01)

Effect of atorvastatin on the most important mechanisms of arrhythmogenesis in patients with ST-elevated myocardial infarction
by: V. E. Oleynikov, et al.
Published: (2019-08-01)

Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
by: Zhaleh Shariati Sarabi, et al.
Published: (2016-08-01)